Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Boston Scientific ( (BSX) ) just unveiled an announcement.
Boston Scientific Corporation has announced the resumption of its AVANT GUARD clinical trial, focusing on drug-naïve patients with persistent atrial fibrillation. This decision follows a thorough assessment and collaboration with the study’s data monitoring committee, signaling potential advancements in treatment options for this patient group.
Find detailed analytics on BSX stock on TipRanks’ Stock Analysis page.
